Cognition Therapeutics, Inc. (CGTX)Healthcare | Biotechnology | Purchase, United States | NasdaqCM
1.19 USD
+0.08
(7.207%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.20 +0.01 (0.622%) ⇧ (April 17, 2026, 7:56 p.m. EDT) Short-term: ★★★★☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:51 a.m. EDT
High-risk momentum play with massive tailwinds; price rebound from $0.6 low to $1.19 signals profit-taking momentum, but non-existent cash flow and negative earnings preclude long-term buy ratings. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.206727 |
| AutoARIMA | 0.223848 |
| AutoTheta | 0.231795 |
| MSTL | 0.235909 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 18% |
| H-stat | 4.89 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 5.00 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.862 |
| Market Cap | 106,331,000 |
| Forward P/E | -3.97 |
| Beta | 1.40 |
| Website | https://www.cogrx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 2.2692308 |
| Address1 | 2,500 Westchester Ave. |
| All Time High | 13.8 |
| All Time Low | 0.222 |
| Ask | 1.24 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 972,030 |
| Average Daily Volume3 Month | 1,066,337 |
| Average Volume | 1,066,337 |
| Average Volume10Days | 972,030 |
| Beta | 1.395 |
| Bid | 1.19 |
| Bid Size | 1 |
| Book Value | 0.385 |
| City | Purchase |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.19 |
| Current Ratio | 3.447 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.2 |
| Day Low | 1.115 |
| Debt To Equity | 1.862 |
| Display Name | Cognition Therapeutics |
| Earnings Call Timestamp End | 1,742,472,000 |
| Earnings Call Timestamp Start | 1,742,472,000 |
| Earnings Timestamp End | 1,762,977,600 |
| Earnings Timestamp Start | 1,762,977,600 |
| Ebitda | -47,763,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.469 |
| Enterprise Value | 70,158,992 |
| Eps Current Year | -0.315 |
| Eps Forward | -0.3 |
| Eps Trailing Twelve Months | -0.32 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.02746 |
| Fifty Day Average Change | 0.16254008 |
| Fifty Day Average Change Percent | 0.15819602 |
| Fifty Two Week Change Percent | 226.92308 |
| Fifty Two Week High | 3.83 |
| Fifty Two Week High Change | -2.6399999 |
| Fifty Two Week High Change Percent | -0.689295 |
| Fifty Two Week Low | 0.222 |
| Fifty Two Week Low Change | 0.96800005 |
| Fifty Two Week Low Change Percent | 4.3603606 |
| Fifty Two Week Range | 0.222 - 3.83 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,633,699,800,000 |
| Float Shares | 82,531,612 |
| Forward Eps | -0.3 |
| Forward P E | -3.9666667 |
| Free Cashflow | -31,391,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 14 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02228 |
| Held Percent Institutions | 0.23575 |
| Implied Shares Outstanding | 89,353,773 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-08 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York. |
| Long Name | Cognition Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 106,331,000 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_39366358 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -23,487,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 106,330,989 |
| Number Of Analyst Opinions | 4 |
| Open | 1.12 |
| Operating Cashflow | -24,588,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 412 481 2210 |
| Post Market Change | 0.0073999166 |
| Post Market Change Percent | 0.6218417 |
| Post Market Price | 1.1974 |
| Post Market Time | 1,776,470,179 |
| Previous Close | 1.11 |
| Price Eps Current Year | -3.777778 |
| Price Hint | 4 |
| Price To Book | 3.0909092 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.356 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.08 |
| Regular Market Change Percent | 7.20721 |
| Regular Market Day High | 1.2 |
| Regular Market Day Low | 1.115 |
| Regular Market Day Range | 1.115 - 1.2 |
| Regular Market Open | 1.12 |
| Regular Market Previous Close | 1.11 |
| Regular Market Price | 1.19 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,282,206 |
| Return On Assets | -0.75992996 |
| Return On Equity | -0.88595 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 89,353,773 |
| Shares Percent Shares Out | 0.0767 |
| Shares Short | 6,854,945 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,139,534 |
| Short Name | Cognition Therapeutics, Inc. |
| Short Percent Of Float | 0.082600005 |
| Short Ratio | 5.27 |
| Source Interval | 15 |
| State | NY |
| Symbol | CGTX |
| Target High Price | 4.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 3.5 |
| Target Median Price | 3.5 |
| Total Cash | 36,810,000 |
| Total Cash Per Share | 0.412 |
| Total Debt | 638,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.32 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.366215 |
| Two Hundred Day Average Change | -0.17621493 |
| Two Hundred Day Average Change Percent | -0.12898038 |
| Type Disp | Equity |
| Volume | 1,282,206 |
| Website | https://www.cogrx.com |
| Zip | 10,577 |